Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim

Oncogene volume 37, pages 2122–2136 (2018)Cite this article

Subjects

Abstract

Phosphorylation of Ser/Thr residues is a well-established modulating mechanism of the pro-apoptotic function of the BH3-only protein Bim. However, nothing is known about the putative tyrosine phosphorylation of this Bcl-2 family member and its potential impact on Bim function and subsequent Bax/Bak-mediated cytochrome c release and apoptosis. As we have previously shown that the tyrosine kinase Lyn could behave as an anti-apoptotic molecule, we investigated whether this Src family member could directly regulate the pro-apoptotic function of Bim. In the present study, we show that Bim is phosphorylated onto tyrosine residues 92 and 161 by Lyn, which results in an inhibition of its pro-apoptotic function. Mechanistically, we show that Lyn-dependent tyrosine phosphorylation of Bim increases its interaction with anti-apoptotic members such as Bcl-xL, therefore limiting mitochondrial outer membrane permeabilization and subsequent apoptosis. Collectively, our data uncover one molecular mechanism through which the oncogenic tyrosine kinase Lyn negatively regulates the mitochondrial apoptotic pathway, which may contribute to the transformation and/or the chemotherapeutic resistance of cancer cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997;13:513–609.

    Article  CAS  Google Scholar 

  2. Ingley E. Functions of the Lyn tyrosine kinase in health and disease. Cell Commun Signal. 2012;10:21.

    Article  CAS  Google Scholar 

  3. Parsons SJ, Parsons JT. Src family kinases, key regulators of signal transduction. Oncogene. 2004;23:7906–9.

    Article  CAS  Google Scholar 

  4. Kim LC, Song L, Haura EB. Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol. 2009;6:587–95.

    Article  Google Scholar 

  5. Harder KW, Parsons LM, Armes J, Evans N, Kountouri N, Clark R, et al. Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage. Immunity. 2001;15:603–15.

    Article  CAS  Google Scholar 

  6. Hibbs ML, Tarlinton DM, Armes J, Grail D, Hodgson G, Maglitto R, et al. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell. 1995;83:301–11.

    Article  CAS  Google Scholar 

  7. Scapini P, Pereira S, Zhang H, Lowell CA. Multiple roles of Lyn kinase in myeloid cell signaling and function. Immunol Rev. 2009;228:23–40.

    Article  CAS  Google Scholar 

  8. Ptasznik A, Nakata Y, Kalota A, Emerson SG, Gewirtz AM. Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells. Nat Med. 2004;10:1187–9.

    Article  CAS  Google Scholar 

  9. Contri A, Brunati AM, Trentin L, Cabrelle A, Miorin M, Cesaro L, et al. Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis. J Clin Invest. 2005;115:369–78.

    Article  CAS  Google Scholar 

  10. Tauzin S, Ding H, Khatib K, Ahmad I, Burdevet D, van Echten-Deckert G, et al. Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts. Blood. 2008;111:2310–20.

    Article  CAS  Google Scholar 

  11. Goldenberg-Furmanov M, Stein I, Pikarsky E, Rubin H, Kasem S, Wygoda M, et al. Lyn is a target gene for prostate cancer: sequence-based inhibition induces regression of human tumor xenografts. Cancer Res. 2004;64:1058–66.

    Article  CAS  Google Scholar 

  12. Chen WS, Kung HJ, Yang WK, Lin W. Comparative tyrosine-kinase profiles in colorectal cancers: enhanced arg expression in carcinoma as compared with adenoma and normal mucosa. Int J Cancer. 1999;83:579–84.

    Article  CAS  Google Scholar 

  13. Mahon FX, Hayette S, Lagarde V, Belloc F, Turcq B, Nicolini F, et al. Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression. Cancer Res. 2008;68:9809–16.

    Article  CAS  Google Scholar 

  14. Gamas P, Marchetti S, Puissant A, Grosso S, Jacquel A, Colosetti P, et al. Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells. Leukemia. 2009;23:1500–6.

    Article  CAS  Google Scholar 

  15. Luciano F, Herrant M, Jacquel A, Ricci JE, Auberger P. The p54 cleaved form of the tyrosine kinase Lyn generated by caspases during BCR-induced cell death in B lymphoma acts as a negative regulator of apoptosis. FASEB J. 2003;17:711–3.

    Article  CAS  Google Scholar 

  16. Zonta F, Pagano MA, Trentin L, Tibaldi E, Frezzato F, Gattazzo C, et al. Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia. Blood. 2014;123:875–83.

    Article  CAS  Google Scholar 

  17. Chipuk JE, Moldoveanu T, Llambi F, Parsons MJ, Green DR. The BCL-2 family reunion. Mol Cell. 2010;37:299–310.

    Article  CAS  Google Scholar 

  18. Green DR, Llambi F. Cell death signaling. Cold Spring Harb Perspect Biol. 2015;7:a006080.

    Article  Google Scholar 

  19. Hubner A, Barrett T, Flavell RA, Davis RJ. Multisite phosphorylation regulates Bim stability and apoptotic activity. Mol Cell. 2008;30:415–25.

    Article  CAS  Google Scholar 

  20. Pinon JD, Labi V, Egle A, Villunger A. Bim and Bmf in tissue homeostasis and malignant disease. Oncogene. 2008;27(Suppl 1):S41–52.

    Article  CAS  Google Scholar 

  21. Luciano F, Jacquel A, Colosetti P, Herrant M, Cagnol S, Pages G, et al. Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene. 2003;22:6785–93.

    Article  CAS  Google Scholar 

  22. Puthalakath H, Huang DC, O’Reilly LA, King SM, Strasser A. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell. 1999;3:287–96.

    Article  CAS  Google Scholar 

  23. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 1999;286:1735–8.

    Article  CAS  Google Scholar 

  24. O’Connor L, Strasser A, O’Reilly LA, Hausmann G, Adams JM, Cory S, et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 1998;17:384–95.

    Article  Google Scholar 

  25. Clybouw C, Merino D, Nebl T, Masson F, Robati M, O’Reilly L, et al. Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo. Cell Death Differ. 2012;19:1060–8.

    Article  CAS  Google Scholar 

  26. Enders A, Bouillet P, Puthalakath H, Xu Y, Tarlinton DM, Strasser A. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med. 2003;198:1119–26.

    Article  CAS  Google Scholar 

  27. Kuroda J, Puthalakath H, Cragg MS, Kelly PN, Bouillet P, Huang DC, et al. Bim and Bad mediate imatinib-induced killing of Bcr/Abl + leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic. Proc Natl Acad Sci USA. 2006;103:14907–12.

    Article  CAS  Google Scholar 

  28. Ricci JE, Lang V, Luciano F, Belhacene N, Giordanengo V, Michel F, et al. An absolute requirement for Fyn in T cell receptor-induced caspase activation and apoptosis. FASEB J. 2001;15:1777–9.

    Article  CAS  Google Scholar 

  29. Ban T, Sato GR, Nishiyama A, Akiyama A, Takasuna M, Umehara M, et al. Lyn kinase suppresses the transcriptional activity of IRF5 in the TLR-MyD88 pathway to restrain the development of autoimmunity. Immunity. 2016;45:319–32.

    Article  CAS  Google Scholar 

  30. Luciano F, Ricci JE, Auberger P. Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: a new mechanism for Src kinase regulation. Oncogene. 2001;20:4935–41.

    Article  CAS  Google Scholar 

  31. Puthalakath H, O’Reilly LA, Gunn P, Lee L, Kelly PN, Huntington ND, et al. ER stress triggers apoptosis by activating BH3-only protein Bim. Cell. 2007;129:1337–49.

    Article  CAS  Google Scholar 

  32. Bouillet P, Purton JF, Godfrey DI, Zhang LC, Coultas L, Puthalakath H, et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 2002;415:922–6.

    Article  CAS  Google Scholar 

  33. Luo S, Garcia-Arencibia M, Zhao R, Puri C, Toh PP, Sadiq O, et al. Bim inhibits autophagy by recruiting Beclin 1 to microtubules. Mol Cell. 2012;47:359–70.

    Article  CAS  Google Scholar 

  34. Gogada R, Yadav N, Liu J, Tang S, Zhang D, Schneider A, et al. Bim, a proapoptotic protein, up-regulated via transcription factor E2F1-dependent mechanism, functions as a prosurvival molecule in cancer. J Biol Chem. 2013;288:368–81.

    Article  CAS  Google Scholar 

  35. Pecot J, Maillet L, Le Pen J, Vuillier C, Trecesson SC, Fetiveau A, et al. Tight sequestration of BH3 proteins by BCL-xL at subcellular membranes contributes to apoptotic resistance. Cell Rep. 2016;17:3347–58.

    Article  CAS  Google Scholar 

  36. Tait SW, Parsons MJ, Llambi F, Bouchier-Hayes L, Connell S, Munoz-Pinedo C, et al. Resistance to caspase-independent cell death requires persistence of intact mitochondria. Dev Cell. 2010;18:802–13.

    Article  CAS  Google Scholar 

  37. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.

    Article  CAS  Google Scholar 

  38. Egle A, Harris AW, Bouillet P, Cory S. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc Natl Acad Sci USA. 2004;101:6164–9.

    Article  CAS  Google Scholar 

  39. Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA, Siebert R, Climent J, Fresquet V, et al. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood. 2007;109:271–80.

    Article  CAS  Google Scholar 

  40. Belloc F, Moreau-Gaudry F, Uhalde M, Cazalis L, Jeanneteau M, Lacombe F, et al. Imatinib and nilotinib induce apoptosis of chronic myeloid leukemia cells through a Bim-dependant pathway modulated by cytokines. Cancer Biol Ther. 2007;6:912–9.

    Article  CAS  Google Scholar 

  41. Sionov RV, Vlahopoulos SA, Granot Z. Regulation of Bim in health and disease. Oncotarget. 2015;6:23058–134.

    Article  Google Scholar 

  42. Ley R, Ewings KE, Hadfield K, Howes E, Balmanno K, Cook SJ. Extracellular signal-regulated kinases 1/2 are serum-stimulated “Bim(EL) kinases” that bind to the BH3-only protein Bim(EL) causing its phosphorylation and turnover. J Biol Chem. 2004;279:8837–47.

    Article  CAS  Google Scholar 

  43. Rooswinkel RW, van de Kooij B, de Vries E, Paauwe M, Braster R, Verheij M, et al. Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity. Blood. 2014;123:2806–15.

    Article  CAS  Google Scholar 

  44. Ingley E. Src family kinases: regulation of their activities, levels and identification of new pathways. Biochim Biophys Acta. 2008;1784:56–65.

    Article  CAS  Google Scholar 

  45. Carpenter RL, Han W, Paw I, Lo HW. HER2 phosphorylates and destabilizes pro-apoptotic PUMA, leading to antagonized apoptosis in cancer cells. PLoS ONE. 2013;8:e78836.

    Article  Google Scholar 

  46. Fox JL, Ismail F, Azad A, Ternette N, Leverrier S, Edelmann MJ, et al. Tyrosine dephosphorylation is required for Bak activation in apoptosis. EMBO J. 2010;29:3853–68.

    Article  CAS  Google Scholar 

  47. Nishizumi H, Taniuchi I, Yamanashi Y, Kitamura D, Ilic D, Mori S, et al. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity. 1995;3:549–60.

    Article  CAS  Google Scholar 

  48. Gross AJ, Proekt I, DeFranco AL. Elevated BCR signaling and decreased survival of Lyn-deficient transitional and follicular B cells. Eur J Immunol. 2011;41:3645–55.

    Article  CAS  Google Scholar 

  49. Leonard JT, Rowley JS, Eide CA, Traer E, Hayes-Lattin B, Loriaux M, et al. Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia. Sci Transl Med. 2016;8:354ra114.

    Article  Google Scholar 

  50. Lopez J, Hesling C, Prudent J, Popgeorgiev N, Gadet R, Mikaelian I, et al. Src tyrosine kinase inhibits apoptosis through the Erk1/2- dependent degradation of the death accelerator Bik. Cell Death Differ. 2012;19:1459–69.

    Article  CAS  Google Scholar 

  51. Bian Y, Li L, Dong M, Liu X, Kaneko T, Cheng K, et al. Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016;12:959–66.

    Article  CAS  Google Scholar 

  52. Mertins P, Mani DR, Ruggles KV, Gillette MA, Clauser KR, Wang P, et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016;534:55–62.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the Fondation ARC pour la Recherche sur le Cancer (#PJA 20131200392 and #PGA1RF201702053889), the Fondation pour la Recherche Médicale (DMP20101120387), the INSERM, the Ministere de la Recherche, and the University of Nice-Sophia-Antipolis. This work and LEA were funded by the French Government (National Research Agency, ANR) through the “Investments for the Future” LABEX SIGNALIFE: program reference #ANR-11-LABX-0028-01. We thank Frederic Larbret for technical support for FACS sorting. We thank Dr. Simon Cook for GST-Bim constructs, Dr. Andreas Villunger for kindly providing the WEHI-231 cell line, Dr. David Rubinsztein for the plasmid encoding human BimEL, and Drs. Doug Green and Stephen Tait for HeLa cells stably expressing Smac-GFP. We thank Drs. Eric Eldering and Fabio Brocco for insights and helpful discussion. We thank the Conseil général des AM et de la région PACA et Corse for its financial support.

Author contributions

SM and PA conceived the project. LEA, EV, PG, and SM conducted the experiments and were assisted by PC, LS, SO, EP. FG and PPJ contributed to the BRET experiments. SM wrote the paper. PA, J-ER, LEA, BB-M, AJ, GR, FL, FG, and PPJ reviewed and edited the paper. SM and PA supervised the study and obtained funding.

Author information

Author notes

  1. Patrick Auberger and Sandrine Marchetti contributed equally to this work.

Authors and Affiliations

  1. Université Côte d’Azur, INSERM, C3M, Nice, France

    Lazaro E. Aira, Elodie Villa, Pascal Colosetti, Parvati Gamas, Laurie Signetti, Sandrine Obba, Emma Proics, Béatrice Bailly-Maitre, Arnaud Jacquel, Guillaume Robert, Frédéric Luciano, Jean-Ehrland Ricci, Patrick Auberger & Sandrine Marchetti

  2. CRCINA, UMR 1232 INSERM, Université de Nantes, Université d’Angers, Institut de Recherche en Santé-Université de Nantes, 8 Quai Moncousu - BP 70721, 44007, Nantes Cedex 1, France

    Fabien Gautier & Philippe P. Juin

  3. Institut de Cancérologie de l’Ouest, Bvd J Monod, Site René Gauducheau, 44805, Saint-Herblain, France

    Fabien Gautier & Philippe P. Juin

Authors
  1. Lazaro E. Aira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elodie Villa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pascal Colosetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Parvati Gamas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Laurie Signetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sandrine Obba
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Emma Proics
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Fabien Gautier
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Béatrice Bailly-Maitre
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Arnaud Jacquel
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Guillaume Robert
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Frédéric Luciano
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Philippe P. Juin
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Jean-Ehrland Ricci
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Patrick Auberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Sandrine Marchetti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sandrine Marchetti.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aira, L.E., Villa, E., Colosetti, P. et al. The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim. Oncogene 37, 2122–2136 (2018). https://doi.org/10.1038/s41388-017-0112-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41388-017-0112-0

Search

Advanced search

Quick links